A retrospective propensity-matched study of 120 hemodynamically stable patients found that chronic SGLT2 inhibitor use was ...
A case report describes a 52-year-old man with dilated cardiomyopathy who developed a rare inferolateral left ventricular ...
ELPIS II 2 Data in HLHS Selected for Late-Breaking Science Program Podium Presentation in the American Heart Association’s (AHA) 2026 Scientific ...
Looney Tunes voice actor Eric Bauza’s cause of death has been determined after he died at the age of 46. Bauza died on Sunday ...
Cumberland Pharmaceuticals Inc. is an innovation-focused biopharmaceutical company developing new therapies to address ...
Clinical Trials Arena on MSN
Alnylam reports preliminary Phase Ib trial results for brezosiran
The trial is designed to assess intrathecal doses of brezosiran in adults aged 25 to 70 years with genetically confirmed HD.
RV, a deep learning model that estimates right ventricular size and function from echocardiograms, and assesses how those ...
Brazilian authorities are investigating the deaths of eight children at a private hospital in São Paulo after grieving ...
Lexeo Therapeutics (NASDAQ:LXEO) outlined its approach to evaluating LX2020, an investigational AAVrh10-based gene therapy for PKP2-associated arrhythmogenic cardiomyopathy, or ACM, ahead of an ...
Cumberland Pharmaceuticals (NASDAQ:CPIX) said it plans to begin a rolling New Drug Application submission for Dyscorban, its ifetroban candidate for cardiomyopathy associated with Duchenne muscular ...
Ventricular involvement in neonatal brain hemorrhage, a serious complication of FNAIT, may be associated with severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results